ZSCAN20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.702800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.436600E-01
Normal-vs-Stage2
6.862200E-01
Normal-vs-Stage3
1.262040E-01
Normal-vs-Stage4
5.772000E-01
Stage1-vs-Stage2
6.598400E-01
Stage1-vs-Stage3
4.790500E-02
Stage1-vs-Stage4
3.844400E-01
Stage2-vs-Stage3
4.359700E-02
Stage2-vs-Stage4
3.975000E-01
Stage3-vs-Stage4
1.618190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.655200E-01
Normal-vs-AfricanAmerican
7.839400E-01
Normal-vs-Asian
5.818600E-01
Caucasian-vs-AfricanAmerican
9.140400E-01
Caucasian-vs-Asian
6.813400E-01
AfricanAmerican-vs-Asian
7.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.465000E-01
Normal-vs-Female
7.095000E-01
Male-vs-Female
7.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.194600E-01
Normal-vs-Age(41-60Yrs)
8.374400E-01
Normal-vs-Age(61-80Yrs)
4.740400E-01
Normal-vs-Age(81-100Yrs)
3.221200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.176400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.791600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.661400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.282880E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.434180E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.321400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.725830E-01
Normal-vs-Daily Drinker
4.979200E-01
Normal-vs-Weekly Drinker
5.413000E-01
Normal-vs-Occasional Drinker
9.977400E-01
Normal-vs-Social Drinker
9.057800E-01
Non Drinker-vs-Daily Drinker
3.649000E-01
Non Drinker-vs-Weekly Drinker
2.522600E-01
Non Drinker-vs-Occasional Drinker
8.604500E-03
Non Drinker-vs-Social Drinker
3.416500E-03
Daily Drinker-vs-Weekly Drinker
8.273000E-01
Daily Drinker-vs-Occasional Drinker
1.619400E-01
Daily Drinker-vs-Social Drinker
1.101770E-01
Weekly Drinker-vs-Occasional Drinker
2.560600E-01
Weekly Drinker-vs-Social Drinker
1.590240E-01
Occasional Drinker-vs-Social Drinker
8.322800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.323000E-01
Normal-vs-Grade 2
6.325800E-02
Normal-vs-Grade 3
7.245600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.238200E-02
Grade 1-vs-Grade 3
2.071600E-02
Grade 1-vs-Grade 4
3.323000E-01
Grade 2-vs-Grade 3
3.871600E-01
Grade 2-vs-Grade 4
6.325800E-02
Grade 3-vs-Grade 4
7.245600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.421600E-01
Normal-vs-NonDiabetic
5.999400E-01
Diabetic-vs-NonDiabetic
2.125400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.583200E-01
Normal-vs-NoPancreatitis
5.131200E-01
Pancreatitis-vs-NoPancreatitis
3.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.487200E-01
Normal-vs-N1
6.546400E-01
N0-vs-N1
8.378200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.493000E-01
Normal-vs-TP53-NonMutant
4.925800E-01
TP53-Mutant-vs-TP53-NonMutant
1.533930E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
